CompX International vs NLI
CIX and NL side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CIX and NL compare
CompX International is the larger company, worth 1.6 times as much as NLI ($562M against $348M).
CompX International grew revenue faster over the last twelve months (6.0% versus 6.0% for NLI).
CompX International keeps more of each dollar of sales as profit, with a net margin of 13.6% compared with −15.8% at NLI.
Both pay dividends: CompX International yields 2.6% and NLI 5.5%.
CompX International scores higher on the StockData Score (14 against 13 for NLI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CIX | NL |
|---|---|---|
| Size and price | ||
| Market cap | $562M | $348M |
| Share price | $45.58 | $7.11 |
| Change, 1 year | 106% | 28.3% |
| Change, 5 years | 107% | 14.5% |
| Beta (5Y) | 0.43 | 0.53 |
| Employees | 549 | 549 |
| StockData Score | ||
| Total score | 14 (better) | 13 |
| Valuation score | 0 | 2 (better) |
| Growth score | 2 | 2 |
| Performance score | 5 (better) | 0 |
| Health score | 6 | 6 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 25.5× | – |
| P/S | 3.5× | 2.1× (better) |
| P/B | 3.9× | 1.0× (better) |
| EV/EBITDA | 17.1× | 14.0× (better) |
| P/FCF | 26.5× (better) | 42.9× |
| FCF yield | 3.8% (better) | 2.3% |
| Fair value | $29.47 | $7.67 |
| Margin of safety | −54.6% | 7.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.0% | 6.0% |
| Revenue growth, 5Y average | 6.7% | 6.7% |
| Net income growth (TTM) | 18.5% (better) | −148% |
| EPS growth (TTM) | 18.5% (better) | −147% |
| EPS growth, 5Y average | 13.7% | – |
| Profitability | ||
| Gross margin | 32.1% | 32.1% |
| Operating margin | 16.3% (better) | 9.2% |
| Net margin | 13.6% (better) | −15.8% |
| FCF margin | 13.1% (better) | 5.0% |
| Return on equity | 15.0% (better) | −6.7% |
| Return on invested capital | 21.4% (better) | 4.4% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | – | 122× |
| Current ratio | 6.69 | 9.02 (better) |
| Altman Z-score | 23.01 (better) | 3.92 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% | 5.5% (better) |
| Payout ratio | 123% | – |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 40.6% (better) | 28.9% |
| Shareholder yield | 2.6% | 5.5% (better) |
| Ownership | ||
| Held by institutions | 6.5% | 11.3% |
| Held by insiders | 0.51% | 0.41% |
| Insider net buying, 12 months | −$44.4K | – |
| Short interest, % of float | 0.92% | 0.19% |
Go deeper
- CIX stock overview
- CIX income statement
- CIX valuation and score
- NL stock overview
- NL income statement
- NL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.